Gene polymorphisms in primary biliary cirrhosis: association with the disease and hepatic osteopathy

Genetic factors have been implicated in the pathogenesis of osteoporosis, a common disorder in primary biliary cirrhosis (PBC). Estrogen receptor-alpha gene (ER-�), vitamin-D-receptor gene (VDR) and IL-1-receptor-antagonist gene (IL-1RN) are all attractive candidates for osteoporosis susceptibility. Furthermore insulin-like growth factor-I (IGF-I) gene microsatellite repeat polymorphism was found to be associated with osteoporosis in some studies and collagen-I�1 (COLIA1) Sp1 s allele was associated with lower bone mineral density (BMD) in one study in PBC. IGF-I treatment restored osteopenia and reduced fibrogenesis in experimental cirrhosis. In this study we summarize our results on polymorphisms of the above genes and bone disease in Hungarian PBC patients. Patients and methods: 70 female patients with PBC were enrolled (age:57.6yrs, range:37-76yrs, each AMA-M2 positive, stage II-IV). 139 age-matched female subjects served as controls (age: 55.9 yrs, range:43-72 yrs). COLIA1 Sp1 and IGF-I microsatellite polymorphisms were determined by PCR in all patients and controls. VDR BsmI, IL-1RN variable-number tandem repeat (VNTR) and ER-� PvuII and XbaI polymorphisms were detected in 33 patients and controls. BMD was measured by dual energy x-ray absorptiometry (Lunar,Prodigy,USA) in lumbar spine (LS) and femoral neck (FN). Results: There was no difference in IGF-I microsatellite repeat polymorphism (192/192=34.2%, 194/192=28.6%, other=37.2%) and COLIA1 Sp1 polymorphism (SS=72.9%, Ss=22.8% and ss=4.3%) and IL-1 VNTR polymorphism between PBC patients and controls, however, the COLIA1 Sp1 s allele was significantly less frequent in patients with PBC (p=0.038). The genotype frequency of VDR BsmI (BB=57.5%, Bb=33.3%, bb=9.1%, p=0.01) and ER-a PvuII (PP=18.2%, Pp=75.6%, pp=6.2%, p=0.03) and XbaI (XX=9.1%, Xx=90.9%, xx=0%, p=0.0003) of the patients was different from that of the control group, with higher frequency of the BB, Pp and Xx genotypes in PBC. Osteoporosis (t score<-2.5) was detected in 22 patients (31.4%). Osteoporotic patients were elder and had longer disease history (p=0.01 for both). An association was found between the IGF-I genotypes and ODM data, the 192/192 genotype was associated with higher FN Z-score compared to other genotypes (p=0.036). Conclusions: In contrast to previous studies the COLIA1 Sp1 s allele was less frequent in patients with PBC, and its presence was not associated with BMD. We confirmed previous findings on higher frequency of VDR BsmI BB genotype in patients with PBC. The ER-α PvuII and XbaI Pp and Xx genotypes were more frequent in PBC patients, while IL-1RN VNTR and IGF-I microsatellite repeat polymorphism was not different. Since IGF-I polymorphism was associated to BMD, it may be hypothesized that not COLIA1 but IGF-I together with other genetic and environmental factors may be involved in the complex regulation of BMD in PBC.

[1]  J. Kanis,et al.  DIAGNOSIS OF OSTEOPOROSIS , 2016 .

[2]  P. Donaldson,et al.  Genetic factors in the pathogenesis of primary biliary cirrhosis. , 2003, Clinics in liver disease.

[3]  P. Lakatos,et al.  High serum osteoprotegerin and low RANKL in primary biliary cirrhosis. , 2003, Journal of hepatology.

[4]  A. Morabito,et al.  Peculiar HLA polymorphisms in Italian patients with primary biliary cirrhosis. , 2003, Journal of hepatology.

[5]  I. Kawamura,et al.  Serum insulinlike growth factor-I in biliary atresia. , 2003, Journal of pediatric surgery.

[6]  S. Krane,et al.  Mutation in collagen‐I that confers resistance to the action of collagenase results in failure of recovery from CCl4‐induced liver fibrosis, persistence of activated hepatic stellate cells, and diminished hepatocyte regeneration , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  A. Uitterlinden,et al.  Collagen Ia1 Polymorphism is Associated with Bone Characteristics in Caucasian Children and Young Adults , 2002, Calcified Tissue International.

[8]  K. Sjögren,et al.  Effects of Liver‐Derived Insulin‐Like Growth Factor I on Bone Metabolism in Mice , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  D. Leroith,et al.  Circulating levels of IGF-1 directly regulate bone growth and density. , 2002, The Journal of clinical investigation.

[10]  M. Pines,et al.  Halofuginone, a collagen type I inhibitor improves liver regeneration in cirrhotic rats. , 2002, Journal of hepatology.

[11]  P. Lakatos,et al.  Vitamin D receptor, oestrogen receptor-alpha gene and interleukin-1 receptor antagonist gene polymorphisms in Hungarian patients with primary biliary cirrhosis , 2002, European journal of gastroenterology & hepatology.

[12]  M. Manns,et al.  Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis , 2002, Hepatology.

[13]  D. Reid,et al.  COL1A1 Sp1 Polymorphism Predicts Perimenopausal and Early Postmenopausal Spinal Bone Loss , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  J. Ioannidis,et al.  Association of Collagen Iα 1 Sp1 Polymorphism with the Risk of Prevalent Fractures: A Meta‐Analysis , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[15]  O. Chazouilleres,et al.  Apolipoprotein E polymorphism, a marker of disease severity in primary biliary cirrhosis? , 2001, Journal of hepatology.

[16]  J. Prieto,et al.  Antifibrogenic effect in vivo of low doses of insulin-like growth factor-I in cirrhotic rats. , 2001, Biochimica et biophysica acta.

[17]  R M Aspden,et al.  A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. , 2001, The Journal of clinical investigation.

[18]  W. Blum,et al.  Circulating levels of insulin-like growth factors and their binding proteins in patients with chronic liver disease: lack of correlation with bone mineral density. , 2001, Liver.

[19]  P. Lakatos,et al.  [Follow-up study of bone mineral density in postmenopausal patients with primary biliary cirrhosis]. , 2001, Orvosi hetilap.

[20]  P. Donaldson,et al.  HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility , 2001, Gut.

[21]  F. Rivera,et al.  Collagen type Iα1 and vitamin D receptor gene polymorphisms and bone mass in primary biliary cirrhosis , 2001 .

[22]  D. Reid,et al.  Estrogen Receptor α Gene Polymorphisms and Bone Mineral Density: Haplotype Analysis in Women from the United Kingdom , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[23]  M. Taniyama,et al.  Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population. , 2000, The Journal of clinical endocrinology and metabolism.

[24]  S. Kikuchi,et al.  Estrogen receptor gene polymorphism in Japanese patients with multiple sclerosis , 2000, Journal of the Neurological Sciences.

[25]  A. Berghold,et al.  Association of the Vitamin D Receptor Genotype BB with Low Bone Density in Hyperthyroidism , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[26]  P. Lakatos,et al.  Lack of association between interleukin-1 receptor antagonist protein gene polymorphism and bone mineral density in Hungarian postmenopausal women. , 2000, Bone.

[27]  C. Rosen IGF-I and osteoporosis. , 2000, Clinics in laboratory medicine.

[28]  B. Halmos,et al.  Association of Primary Biliary Cirrhosis with Vitamin D Receptor BsmI Genotype Polymorphism in a Hungarian Population , 2000, Digestive Diseases and Sciences.

[29]  A. Ho,et al.  PvuII Polymorphisms of the Estrogen Receptor α and Bone Mineral Density in Healthy Southern Chinese Women , 2000, Calcified Tissue International.

[30]  M. Evans,et al.  Molecular mechanisms involved in the estrogen-dependent regulation of calcineurin in systemic lupus erythematosus T cells. , 2000, Clinical immunology.

[31]  R. Honkanen,et al.  Early Postmenopausal Bone Loss Is Associated with PvuII Estrogen Receptor Gene Polymorphism in Finnish Women: Effect of Hormone Replacement Therapy , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[32]  Y. Bagger,et al.  No major effect of estrogen receptor gene polymorphisms on bone mineral density or bone loss in postmenopausal Danish women. , 2000, Bone.

[33]  I. Okan,et al.  Serum Concentrations of Insulin-like Growth Factor-I and Insulin-like Growth Factor Binding Protein-3 in Patients with Chronic Hepatitis , 2000, Scandinavian journal of gastroenterology.

[34]  Daniel L. Koller,et al.  Sibling pair linkage and association studies between bone mineral density and the insulin-like growth factor I gene locus. , 1999, The Journal of clinical endocrinology and metabolism.

[35]  P. Geusens,et al.  Lack of association between estrogen receptor genotypes and bone mineral density, fracture history, or muscle strength in elderly women. , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[36]  R. Fox,et al.  Estrogen in autoimmunity: expression of estrogen receptors in thymic and autoimmune T cells. , 1999, The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia.

[37]  C. Rosen,et al.  Serum insulin-like growth factors and insulin-like growth factor-binding proteins: clinical implications. , 1999, Clinical chemistry.

[38]  F. Vleggaar,et al.  Prevention and treatment of osteoporosis in primary biliary cirrhosis. , 1999, European journal of gastroenterology & hepatology.

[39]  H. Whittle,et al.  Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. , 1999, The Journal of infectious diseases.

[40]  S. Pereira,et al.  Non-invasive assessment of bone density in primary biliary cirrhosis. , 1999, European journal of gastroenterology & hepatology.

[41]  J. Féher,et al.  Significant differences in the interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in a Hungarian population with inflammatory bowel disease. , 1999, Scandinavian journal of gastroenterology.

[42]  Mark L. Johnson,et al.  Change of bone mass in postmenopausal Caucasian women with and without hormone replacement therapy is associated with vitamin D receptor and estrogen receptor genotypes , 1998, Human Genetics.

[43]  Clavreul,et al.  Vitamin D differentially regulates B7.1 and B7.2 expression on human peripheral blood monocytes , 1998, Immunology.

[44]  T. Spector,et al.  Allelic variation at the interleukin-1 receptor antagonist gene is associated with early postmenopausal bone loss at the spine. , 1998, Bone.

[45]  J. Bilezikian,et al.  Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density. , 1998, The Journal of clinical endocrinology and metabolism.

[46]  C. Bunten,et al.  Bone Mineral Density and Its Change in White Women: Estrogen and Vitamin D Receptor Genotypes and Their Interaction , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[47]  E. G. de la Concha,et al.  Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis , 1997, Journal of Neuroimmunology.

[48]  R. Coppel,et al.  In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: Predominance of the Th1 subset , 1997, Hepatology.

[49]  J. Rodés,et al.  Osteoporosis and Bone Mineral Metabolism Disorders in Cirrhotic Patients Referred for Orthotopic Liver Transplantation , 1997, Calcified Tissue International.

[50]  G. Cooper,et al.  Are vitamin D receptor polymorphisms associated with bone mineral density? A meta‐analysis , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[51]  K. Tsai,et al.  Bone mineral density and bone markers in relation to vitamin D receptor gene polymorphisms in Chinese men and women. , 1996, Bone.

[52]  S. Grant,et al.  Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I α 1 gene , 1996, Nature Genetics.

[53]  P. Delmas,et al.  Vitamin D receptor gene polymorphisms are not related to bone turnover, rate of bone loss, and bone mass in postmenopausal women: The OFELY study , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[54]  Y. Ouchi,et al.  Association of bone mineral density with polymorphism of the estrogen receptor gene , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[55]  G. Siest,et al.  Segregation analysis and variance components analysis of bone mineral density in healthy families , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[56]  B. Dawson-Hughes,et al.  The BsmI vitamin D receptor restriction fragment length polymorphism (BB) predicts low bone density in premenopausal black and white women , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[57]  J. Lemire Immunomodulatory actions of 1,25-Dihydroxyvitamin D3 , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[58]  E. Dickson,et al.  Bone disease in primary biliary cirrhosis: Does ursodeoxycholic acid make a difference? , 1995, Hepatology.

[59]  D. Grennan,et al.  Cytokine production by normal human monocytes: inter‐subject variation and relationship to an IL‐1 receptor antagonist (IL‐1Ra) gene polymorphism , 1995, Clinical and experimental immunology.

[60]  K. Korach Insights from the study of animals lacking functional estrogen receptor. , 1994, Science.

[61]  B. Riggs,et al.  Circulating cytokine levels in osteoporotic and normal women. , 1994, The Journal of clinical endocrinology and metabolism.

[62]  J. Eisman,et al.  Prediction of bone density from vitamin D receptor alleles , 1994, Nature.

[63]  E. Dickson,et al.  Rates of cancellous bone remodeling and turnover in osteopenia associated with primary biliary cirrhosis. , 1993, Bone.

[64]  A. Blakemore,et al.  Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat , 1993, Human Genetics.

[65]  L. Bonewald,et al.  Interleukin‐1 receptor antagonist inhibits the hypercalcemia mediated by interleukin‐1 , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[66]  F. Rivera,et al.  Factors influencing the development of metabolic bone disease in primary biliary cirrhosis. , 1990, The American journal of gastroenterology.

[67]  J. Hopper,et al.  Genetic determinants of bone mass in adults. A twin study. , 1987, The Journal of clinical investigation.

[68]  M. Kaplan,et al.  Primary Biliary Cirrhosis , 1987, The New England journal of medicine.

[69]  S. Arnaud 25-Hydroxyvitamin D3 treatment of bone disease in primary biliary cirrhosis. , 1982, Gastroenterology.

[70]  Z. Varghese,et al.  Clinical, biochemical, and histological studies of osteomalacia, osteoporosis, and parathyroid function in chronic liver disease. , 1978, Gut.

[71]  R. Kalluri,et al.  Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors. , 2003, Gastroenterology.

[72]  E. Martín Mola,et al.  Polymorphism in the type I collagen (COLIA1) gene and risk of fractures in postmenopausal women. , 2002, Bone.

[73]  F. Rivera,et al.  Collagen type Ialpha1 and vitamin D receptor gene polymorphisms and bone mass in primary biliary cirrhosis. , 2001, Hepatology.

[74]  D. Cole,et al.  Vitamin D-receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis. , 2000, Gastroenterology.

[75]  S. Saitoh,et al.  Correlation of a polymorphism in the interleukin-1 receptor antagonist gene with hepatic fibrosis in Japanese alcoholics. , 1998, Alcoholism, clinical and experimental research.

[76]  C. Gabay,et al.  Interleukin-1 receptor antagonist: role in biology. , 1998, Annual review of immunology.

[77]  A. Blakemore,et al.  Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene. , 1995, The Journal of clinical endocrinology and metabolism.

[78]  E. Dickson,et al.  Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment. , 1994, The American journal of gastroenterology.

[79]  J. Compston,et al.  Low bone turnover state in primary biliary cirrhosis , 1987, Hepatology.

[80]  J. Talwalkar,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Primary Biliary Cirrhosis , 2022 .